Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries
NCT02668341 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1304
Last updated 2020-11-05
Summary
Analysis of barriers in psoriasis care from the patient's and the physician's perspective and generation of scientific data on the quality of health care in Denmark, Poland, Spain, and Germany
Conditions
Interventions
- OTHER
-
non-interventional
non-interventional survey study
Sponsors & Collaborators
- collaborator INDUSTRY
-
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Principal Investigators
-
Matthias Augustin, Prof. Dr. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2020-09-30
- Completion
- 2020-12-31
Countries
- Denmark
- Germany
- Poland
- Spain
Study Locations
More Related Trials
-
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
NCT02969018 ·Status: COMPLETED ·Phase: PHASE2
-
Improvement of Psoriasis Patients' Adherence to Topical Drugs
NCT04220554 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
NCT01147874 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
NCT05268016 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis
NCT01947491 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients
NCT02908347 ·Status: COMPLETED ·Phase: PHASE2
-
The PsoTeenQOL - Preliminary Reliability and Validity
NCT03358914 ·Status: COMPLETED
-
Clinical Assessment and Psychosocial Impact of Psoriasis
NCT01964443 ·Status: COMPLETED
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
NCT00236171 ·Status: COMPLETED ·Phase: NA
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Education Program in Psoriasis
NCT02310204 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
NCT00195507 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis
NCT02192164 ·Status: COMPLETED
-
Dietary Approach to Mild-to-moderate Psoriasis
NCT05644782 ·Status: RECRUITING ·Phase: NA
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02445807 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
NCT03850483 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
NCT00606450 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis
NCT03004846 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis
NCT02239666 ·Status: COMPLETED
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
NCT06801821 ·Status: RECRUITING
-
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT00678210 ·Status: COMPLETED ·Phase: PHASE2